Apimeds Pharmaceuticals US, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kim Christopher | Chairman and CMO | Award / Grant | 250,000 | — | — | 277,500 | May 16, 2025 |
| Emerson Erik C. | Chief Executive Officer | Award / Grant | 750,000 | — | — | 750,000 | May 16, 2025 |
| Kim Christopher | Chairman and CMO | Purchase | 19,770 | $1.82 | $35,981 | 19,770 | May 14, 2025 |
| Koo Jakap | — | Purchase | 28,500 | $1.99 | $56,715 | 643,885 | May 12, 2025 |
| Inscobee Inc. | — | Purchase | 500,000 | $4.00 | $2,000,000 | 1,984,616 | May 12, 2025 |
| Inscobee Inc. | — | C | 71,090 | $2.60 | $184,834 | 2,055,706 | May 12, 2025 |